TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
IMUX

Immunic Inc

Healthcare · Biotechnology

9.30$ -0.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Immunic Inc (IMUX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 159 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMUX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
67 54 104 86 65 41 21 61 41 24 190 159
65 53 103 85 63 39 19 60 39 23 189 158
60 47 97 80 59 36 14 55 35 15 187 155
60 47 97 80 59 36 14 55 35 15 187 155
1.2 0.7 1.4 1.5 0.8 0.7 0.6 0.6 0.2 4.1 0.4 –
2.3 – – – – – – – – – – –
19 25 21 23 24 22 26 28 30 31 39 32
18 25 20 23 23 22 26 27 30 31 38 31
0.7 0.7 0.7 0.7 0.7 0.7 0.8 0.8 0.7 0.5 0.3 0.2
3.2 5.1 6.2 7.6 5.8 7.8 5.5 7.9 7.3 10 11 13
48 29 84 64 41 18 -5.3 34 10 -6.7 151 128
-389 -411 -440 -462 -486 -511 -537 -564 -589 -609 -641 -675
4.5 4.5 9.7 10 10 9.0 10 13 19 12 30 43

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?